Lin Chen

9.0k total citations · 2 hit papers
270 papers, 5.9k citations indexed

About

Lin Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lin Chen has authored 270 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Molecular Biology, 72 papers in Oncology and 57 papers in Cancer Research. Recurrent topics in Lin Chen's work include RNA modifications and cancer (34 papers), Cancer-related molecular mechanisms research (30 papers) and Circular RNAs in diseases (27 papers). Lin Chen is often cited by papers focused on RNA modifications and cancer (34 papers), Cancer-related molecular mechanisms research (30 papers) and Circular RNAs in diseases (27 papers). Lin Chen collaborates with scholars based in China, United States and France. Lin Chen's co-authors include Yongheng Chen, Yun Li, Na Liu, Sergey Leonov, Yulia Merkher, Huajun Zhang, Alain Carpentier, Jean‐Yves Delattre, Anjana Rao and Chi Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Lin Chen

249 papers receiving 5.9k citations

Hit Papers

Recent advances in therapeutic strategies for triple-nega... 2022 2026 2023 2024 2022 2025 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recent advances in therapeutic strategies for triple-negative breast cancer
    2022 519 citations Lin Chen et al. profile →
  2. Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer
    2025 18 citations Lin Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Chen China 39 3.2k 1.3k 1.2k 961 845 270 5.9k
Xia Gao China 36 2.7k 0.9× 828 0.7× 950 0.8× 829 0.9× 825 1.0× 127 6.0k
Michael Fiegl Austria 37 2.3k 0.7× 1.9k 1.5× 1.1k 0.9× 841 0.9× 852 1.0× 165 5.9k
Jian Chen China 42 3.5k 1.1× 535 0.4× 1.3k 1.1× 953 1.0× 344 0.4× 329 7.0k
Rajani Ravi United States 35 4.6k 1.4× 2.0k 1.6× 2.3k 2.0× 887 0.9× 529 0.6× 43 7.9k
Yanru Wang China 43 4.0k 1.3× 1.4k 1.1× 1.2k 1.0× 864 0.9× 704 0.8× 226 6.7k
Liang Chen China 43 4.1k 1.3× 1.8k 1.4× 1.0k 0.9× 869 0.9× 1.7k 2.0× 217 7.3k
Gaetano Cairo Italy 52 3.8k 1.2× 1.8k 1.4× 1.0k 0.8× 709 0.7× 1.0k 1.2× 140 10.8k
Martin Schreiber Austria 40 3.6k 1.1× 2.1k 1.7× 1.2k 1.0× 607 0.6× 540 0.6× 127 6.6k
Yili Yang China 45 4.5k 1.4× 1.5k 1.2× 1.0k 0.9× 1.3k 1.3× 310 0.4× 103 7.2k
Grazia Graziani Italy 43 3.6k 1.1× 2.6k 2.1× 702 0.6× 890 0.9× 485 0.6× 197 6.3k

Countries citing papers authored by Lin Chen

Since Specialization
Citations

This map shows the geographic impact of Lin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Chen more than expected).

Fields of papers citing papers by Lin Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Chen. The network helps show where Lin Chen may publish in the future.

Co-authorship network of co-authors of Lin Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Chen. A scholar is included among the top collaborators of Lin Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Chen. Lin Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Lin, Jin Yang, Hanna Liao, et al.. (2025). Chrysin inhibits hypertrophic scar formation through TGF-β/Smad signaling pathways. Journal of Molecular Histology. 56(5). 298–298. 1 indexed citations
2.
Yang, Mengyu, Xiaoyu Chen, Yongqian Liu, et al.. (2025). The anti-metastatic effect of elemene in human hepatocellular carcinoma is potentially mediated by inhibiting a novel driver-circBPTF. Phytomedicine. 143. 156808–156808.
3.
4.
Chen, Lin, Kunpeng Li, Qingjie Li, et al.. (2024). Global burdens of nasopharyngeal carcinoma in children and young adults and predictions to 2040. Oral Oncology. 155. 106891–106891. 12 indexed citations
5.
Deng, Chunyan, Lin Chen, Xiaoliang Wang, et al.. (2024). Zinc-alpha2-glycoprotein modulates blood pressure by regulating renal lipid metabolism reprogramming-mediated urinary Na+ excretion in hypertension. Cardiovascular Research. 120(16). 2134–2146. 4 indexed citations
6.
Jiang, Jiao, Hongjuan Li, Lin Chen, & Xiaoming Qiu. (2024). Prognostic value of albumin-bilirubin grade in lung cancer: a meta-analysis. Journal of Cardiothoracic Surgery. 19(1). 685–685. 2 indexed citations
7.
Miao, Wenjie, et al.. (2024). Global, Regional, and National Burden of Nasopharyngeal Carcinoma from 1990 to 2021. The Laryngoscope. 135(4). 1409–1418. 3 indexed citations
8.
9.
Li, Shoupeng, et al.. (2023). Causal association of calcific aortic valve stenosis and atrial fibrillation: a Mendelian randomization study. Scientific Reports. 13(1). 20284–20284. 1 indexed citations
10.
Jiang, Dongbo, et al.. (2023). CDK4/6i enhances the antitumor effect of PD1 antibody by promoting TLS formation in ovarian cancer. Heliyon. 9(9). e19760–e19760. 6 indexed citations
11.
Yue, Wen, Lin Chen, Dongli Chen, et al.. (2022). The accumulation of miR-125b-5p is indispensable for efficient erythroblast enucleation. Cell Death and Disease. 13(10). 886–886. 1 indexed citations
12.
Zhu, Yinghong, Xuewen Yang, Jing Zhou, et al.. (2022). miR‐340‐5p Mediates Cardiomyocyte Oxidative Stress in Diabetes‐Induced Cardiac Dysfunction by Targeting Mcl‐1. Oxidative Medicine and Cellular Longevity. 2022(1). 3182931–3182931. 24 indexed citations
13.
14.
Dong, Peixin, Ying Xiong, Jiehai Yu, et al.. (2018). Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer. Oncogene. 37(39). 5257–5268. 98 indexed citations
15.
Duan, Hong‐Chao, Lian-Huan Wei, Chi Zhang, et al.. (2017). ALKBH10B Is an RNA N 6 -Methyladenosine Demethylase Affecting Arabidopsis Floral Transition. The Plant Cell. 29(12). 2995–3011. 307 indexed citations
16.
Liu, Qing, Lin Chen, Min Qian, et al.. (2015). Clinical, neuropathological and genetic findings in patients with transthyretin-associated familial amyloid polyneuropathy. Chin J Neurol. 48(1). 7–12. 2 indexed citations
17.
Dai, Yi, Xin Yi, Haitao Ren, Yanhuan Zhao, & Lin Chen. (2015). Clinical manifestations and gene diagnosis of collagen type VI related myopathy. Chin J Neurol. 48(11). 974–979.
18.
Chen, Lin. (2011). The Expression and Clinical Significance of MTA1 Protein in Cervical Cancers. 1 indexed citations
19.
Wiederschain, Dmitri, Lin Chen, Alice Loo, et al.. (2009). Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle. 8(3). 498–504. 306 indexed citations
20.
Ziada, Ali, Albaha Barqawi, L. Michael Glode, et al.. (2004). The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial. The Prostate. 60(4). 332–337. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xia Gao Breakdown of academic impact, for papers by Michael Fiegl Breakdown of academic impact, for papers by Jian Chen Breakdown of academic impact, for papers by Rajani Ravi Breakdown of academic impact, for papers by Yanru Wang Breakdown of academic impact, for papers by Liang Chen Breakdown of academic impact, for papers by Gaetano Cairo Breakdown of academic impact, for papers by Martin Schreiber Breakdown of academic impact, for papers by Yili Yang Breakdown of academic impact, for papers by Grazia Graziani
Rankless by CCL
2026